Metraipolis › archive › dc_b7731ab5cfcf

Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42375370
DOI
10.3389/fimmu.2026.1831234
License (as archived)
solo-consultazione
Archived
2026-10-31T10:48:08.105Z
SHA-256 of the archived text
5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c
Stable URL of this page
https://metraipolis.com/documento/dc_b7731ab5cfcf

How to cite

Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370 — Europe PMC (en), https://europepmc.org/article/MED/42375370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b7731ab5cfcf (Metraipolis archive dc_b7731ab5cfcf, sha256 5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c)
BibTeX
@misc{dcb7731ab5cfcf,
  title = {Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification — Europe PMC PMID:42375370},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42375370},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b7731ab5cfcf; sha256 5f71a1c88527d46c71b7ae323432114253c8ee3951bad02335c74b1170713a8c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42375370. Agents can read the archived copy with the MCP tool read_document.